BACKGROUND AND PURPOSE: Acute ischemic lesions with restricted diffusion can resolve after early recanalization. The impact of superimposed perfusion abnormalities on the fate of acute diffusion lesions is unclear. METHODS: Data were obtained from DEFUSE, a prospective multicenter study of patients treated with IV tPA 3 to 6 hours after stroke onset. Thirty-two patients with baseline diffusion and perfusion lesions and 30 day FLAIR scans were coregistered. The acute diffusion lesion was divided into 3 regions according to the Tmax delay of the superimposed perfusion lesion: normal baseline perfusion; mild-moderately hypoperfused (2 s<Tmax<or=8 s) and severely hypoperfused (Tmax >8 s). The reversal rate was calculated as the percentage of the acute diffusion lesion that did not overlap with the final infarct on 30-day FLAIR. Diffusion reversal rates were compared based on whether a favorable clinical response occurred and whether early recanalization was achieved. RESULTS: On average, 54% of the acute diffusion lesion volume had normal perfusion. Diffusion reversal rates were significantly increased among cases with favorable clinical response and in patients with early recanalization, especially in regions with normal baseline perfusion. The portion of the diffusion lesion with normal perfusion had significantly higher mean apparent diffusion coefficient values and reversal rates. CONCLUSIONS: Acute ischemic lesions with restricted diffusion are most likely to recover if reperfusion occurs within 6 hours of symptom onset, and reversibility is associated with early recanalization and favorable clinical outcome. We propose the term RADAR (Reversible Acute Diffusion lesion Already Reperfused) to describe regions of acute restricted diffusion with normal perfusion.
BACKGROUND AND PURPOSE: Acute ischemic lesions with restricted diffusion can resolve after early recanalization. The impact of superimposed perfusion abnormalities on the fate of acute diffusion lesions is unclear. METHODS: Data were obtained from DEFUSE, a prospective multicenter study of patients treated with IV tPA 3 to 6 hours after stroke onset. Thirty-two patients with baseline diffusion and perfusion lesions and 30 day FLAIR scans were coregistered. The acute diffusion lesion was divided into 3 regions according to the Tmax delay of the superimposed perfusion lesion: normal baseline perfusion; mild-moderately hypoperfused (2 s<Tmax<or=8 s) and severely hypoperfused (Tmax >8 s). The reversal rate was calculated as the percentage of the acute diffusion lesion that did not overlap with the final infarct on 30-day FLAIR. Diffusion reversal rates were compared based on whether a favorable clinical response occurred and whether early recanalization was achieved. RESULTS: On average, 54% of the acute diffusion lesion volume had normal perfusion. Diffusion reversal rates were significantly increased among cases with favorable clinical response and in patients with early recanalization, especially in regions with normal baseline perfusion. The portion of the diffusion lesion with normal perfusion had significantly higher mean apparent diffusion coefficient values and reversal rates. CONCLUSIONS: Acute ischemic lesions with restricted diffusion are most likely to recover if reperfusion occurs within 6 hours of symptom onset, and reversibility is associated with early recanalization and favorable clinical outcome. We propose the term RADAR (Reversible Acute Diffusion lesion Already Reperfused) to describe regions of acute restricted diffusion with normal perfusion.
Authors: M E Moseley; J Kucharczyk; J Mintorovitch; Y Cohen; J Kurhanewicz; N Derugin; H Asgari; D Norman Journal: AJNR Am J Neuroradiol Date: 1990-05 Impact factor: 3.825
Authors: Jens Fiehler; Mascha Foth; Thomas Kucinski; Renée Knab; Michael von Bezold; Cornelius Weiller; Hermann Zeumer; Joachim Röther Journal: Stroke Date: 2002-01 Impact factor: 7.914
Authors: C S Kidwell; J L Saver; J Mattiello; S Starkman; F Vinuela; G Duckwiler; Y P Gobin; R Jahan; P Vespa; M Kalafut; J R Alger Journal: Ann Neurol Date: 2000-04 Impact factor: 10.422
Authors: Ludy C Shih; Jeffrey L Saver; Jeffry R Alger; Sidney Starkman; Megan C Leary; Fernando Vinuela; Gary Duckwiler; Y Pierre Gobin; Reza Jahan; J Pablo Villablanca; Paul M Vespa; Chelsea S Kidwell Journal: Stroke Date: 2003-05-08 Impact factor: 7.914
Authors: Jens Fiehler; Karina Knudsen; Thomas Kucinski; Chelsea S Kidwell; Jeffry R Alger; Götz Thomalla; Bernd Eckert; Oliver Wittkugel; Cornelius Weiller; Hermann Zeumer; Joachim Röther Journal: Stroke Date: 2004-01-22 Impact factor: 7.914
Authors: Chelsea S Kidwell; Jeffrey L Saver; Sidney Starkman; Gary Duckwiler; Reza Jahan; Paul Vespa; J Pablo Villablanca; David S Liebeskind; Y Pierre Gobin; Fernando Vinuela; Jeffry R Alger Journal: Ann Neurol Date: 2002-12 Impact factor: 10.422
Authors: Jean-Marc Olivot; Michael Mlynash; Vincent N Thijs; Stephanie Kemp; Maarten G Lansberg; Lawrence Wechsler; Roland Bammer; Michael P Marks; Gregory W Albers Journal: Stroke Date: 2008-12-24 Impact factor: 7.914
Authors: Christopher D d'Esterre; Richard I Aviv; Laura Morrison; Enrico Fainardi; Ting Yim Lee Journal: Transl Stroke Res Date: 2015-04-15 Impact factor: 6.829
Authors: Amie W Hsia; Marie Luby; Kaylie Cullison; Shannon Burton; Rocco Armonda; Ai-Hsi Liu; Richard Leigh; Zurab Nadareishvili; Richard T Benson; John K Lynch; Lawrence L Latour Journal: Stroke Date: 2019-06-26 Impact factor: 7.914
Authors: A D Horsch; J W Dankbaar; J M Niesten; T van Seeters; I C van der Schaaf; Y van der Graaf; W P Th M Mali; B K Velthuis Journal: AJNR Am J Neuroradiol Date: 2015-04-23 Impact factor: 3.825
Authors: Bruce C V Campbell; Archana Purushotham; Soren Christensen; Patricia M Desmond; Yoshinari Nagakane; Mark W Parsons; Maarten G Lansberg; Michael Mlynash; Matus Straka; Deidre A De Silva; Jean-Marc Olivot; Roland Bammer; Gregory W Albers; Geoffrey A Donnan; Stephen M Davis Journal: J Cereb Blood Flow Metab Date: 2011-07-20 Impact factor: 6.200
Authors: Clinton D Morgan; Marcus Stephens; Scott L Zuckerman; Magarya S Waitara; Peter J Morone; Michael C Dewan; J Mocco Journal: Interv Neuroradiol Date: 2015-06-10 Impact factor: 1.610